HACKENSACK, N.J.and PETACH TIKVAH, Israel, March 18, 2015 \/PRNewswire\/ --BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that CEO Tony Fiorino, MD, PhD, will present at the 3rd Annual Regen Med Investor Day to be held Wednesday, March 25, 2015 in New York City. <\/p>\n
Organized by the Alliance for Regenerative Medicine (ARM) and co-hosted with Piper Jaffray, this one-day investor meeting provides institutional, strategic and venture investors with unique insight into the financing hypothesis for advanced therapies-based treatment and tools. The program includes clinical and commercial experts who are on-hand to address specific questions regarding the outlook for these products, as well as offer insight into how advanced therapies could impact the standard of care in key therapeutic areas. In addition to presentations by more than 30 leading companies from across the globe, the event includes dynamic, interactive panels featuring research analysts covering the space, key clinical opinion leaders and top company CEOs. These discussions will explore themes specific to cell and gene therapy such as commercialization, market access and pricing for breakthrough technologies, gene therapy delivery and upcoming milestones in the adoptive T-cell therapy space. <\/p>\n
The following are specific details regarding BrainStorm's presentation: <\/p>\n
Event: <\/p>\n
ARM's Regen Med Investor Day <\/p>\n
Date: <\/p>\n
March 25, 2015 <\/p>\n
Time: <\/p>\n
4:20 PM EST <\/p>\n
Location: <\/p>\n
<\/p>\n
View original post here: <\/p>\n
BrainStorm Cell Therapeutics to Present at 3rd Annual Regen Med Investor Day on March 25 in New York<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" HACKENSACK, N.J.and PETACH TIKVAH, Israel, March 18, 2015 \/PRNewswire\/ --BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that CEO Tony Fiorino, MD, PhD, will present at the 3rd Annual Regen Med Investor Day to be held Wednesday, March 25, 2015 in New York City Continue reading